Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16
Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Authors Yoshimatsu Y , Tobino K, Sueyasu T, Nishizawa S, Ko Y, Yasuda M, Ide H, Tsuruno K, Miyajima H
Received 4 May 2021
Accepted for publication 4 May 2021
Published 10 May 2021 Volume 2021:16 Pages 1285—1286
Yoshimatsu Y, Tobino K, Sueyasu T, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:2777–2785.
Page 2780, left column, line 2, the text “42.9% and 96.4%” should read “96.4% and 42.9%”.
Page 2780, left column, lines 1 and 2 from the bottom, the text “[…] in patients with a history of exacerbation in the past year than in those with no such history […]” should read “[…] in patients with no history of exacerbation in the past year than in those with a history […]”.
Figure 1 on page 2780, the sensitivity and specificity values are incorrect. The correct Figure 1 is shown below.
Page 2781, Figure 2 legend, the text “[…] in patients with a history of exacerbation in the past year than in those with no such history […]” should read “[…] in patients with no history of exacerbation in the past year than in those with a history […]”.
Page 2782, Figure 3 legend, the text “[…] in patients with a history of exacerbation in the past year than in those with no such history […]” should read “[…] in patients with no history of exacerbation in the past year than in those with a history […]”.
The authors apologize for these errors and advise they do not affect the results of the paper.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.